以下展示近年（仅2022年）发表的代表性文章，及授权的代表性专利，更多内容可详见医院官网。
近年发表的代表性文章（仅2022年）
1、文章题目：Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy
发表期刊：Acta Biomater
2、文章题目：RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma Progression
发表期刊：Cancer Research
3、文章题目：Lu3+-based Nanoprobe for Virtual non-contrast CT Imaging of Hepatocellular Carcinoma
发表期刊：Journal of Controlled Release
4、文章题目：SARS-CoV-2 Spike Spurs Intestinal Inflammation via VEGF Production in Enterocytes
发表期刊：EMBO Molecular Medicine
5、文章题目：SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK
发表期刊：Cell Death & Differentiation
6、文章题目：Enhancing Autophagy Maturation with CCZ1-MON1A Complex Alleviates Neuropathology and Memory Defects in Alzheimer Disease Models
发表期刊：Theranostics
近年授权的代表性专利（仅2022年）
